Maciej J. Krzakowski

Maciej J. Krzakowski

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications

Patients with cardiac implantable electronic devices undergoing radiation therapy for cancer or magnetic resonance imaging.

Patients with cardiac implantable electronic devices undergoing radiation therapy for cancer or magnetic resonance imaging.

Journal: Kardiologia polska
Published: July 27, 2026

Impact of age and histological type on programmed death-ligand 1 expression in non-small cell lung cancer - a single-center analysis of 1,606 cases.

Impact of age and histological type on programmed death-ligand 1 expression in non-small cell lung cancer - a single-center analysis of 1,606 cases.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists
Published: January 19, 2026

"Variant matters": the impact of ALK fusion subtypes on progression and response in non-small-cell lung cancer-data from clinical practice from Polish centers.

"Variant matters": the impact of ALK fusion subtypes on progression and response in non-small-cell lung cancer-data from clinical practice from Polish centers.

Journal: Translational lung cancer research
Published: November 25, 2025

Understanding Cardio-Oncology: A Survey-Based Study Conducted by the Heart Failure Association of the Polish Cardiac Society and the Polish Society of Clinical Oncology.

Understanding Cardio-Oncology: A Survey-Based Study Conducted by the Heart Failure Association of the Polish Cardiac Society and the Polish Society of Clinical Oncology.

Journal: Journal of clinical medicine
Published: November 19, 2025

Clinicopathologic Characteristics, Treatment Outcomes, and Survival in Thymic Neuroendocrine Neoplasms (t-NEN): A 25-Year Single-Center Experience.

Clinicopathologic Characteristics, Treatment Outcomes, and Survival in Thymic Neuroendocrine Neoplasms (t-NEN): A 25-Year Single-Center Experience.

Journal: Cancers
Published: October 26, 2025

Best Practices and Communication Strategies for Informing Oncology Patients About Treatment Discontinuation and Transition to Palliative Care-A Practical Guide for Oncologists.

Best Practices and Communication Strategies for Informing Oncology Patients About Treatment Discontinuation and Transition to Palliative Care-A Practical Guide for Oncologists.

Journal: Cancers
Published: October 05, 2025

Radiation Recall Pneumonitis with Pneumocystis jirovecii Superinfection and Treatment Induced Hyponatremia in a Patient with Non-Small-Cell Lung Cancer.

Radiation Recall Pneumonitis with Pneumocystis jirovecii Superinfection and Treatment Induced Hyponatremia in a Patient with Non-Small-Cell Lung Cancer.

Journal: Diseases (Basel, Switzerland)
Published: September 18, 2025

Efficacy and safety of first-line immune checkpoint inhibitors in patients with PD-L1 <1% metastatic non-small-cell lung cancer - implications for daily clinical practice.

Efficacy and safety of first-line immune checkpoint inhibitors in patients with PD-L1 <1% metastatic non-small-cell lung cancer - implications for daily clinical practice.

Journal: Expert review of anticancer therapy
Published: September 15, 2025

TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 12, 2025

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy.

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy.

Journal: Journal of hematology & oncology
Published: August 04, 2025

Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients.

Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients.

Journal: European cardiology
Published: July 08, 2025

Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancer.

Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancer.

Journal: Cancer
Published: May 30, 2025
Showing 1-12 of 105

Last Updated: 09/26/2026